Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Author Archives: Warren Woessner
Regents of the U. of Cal. v. Broad Inst. – “Just The Facts, Ma’am.”
The central theme in this interference decision involving U.S. Pat. No. 8,697,359 is the amount and type of evidence required to support the conception of an invention. Joe Friday wanted the witness to focus on the facts of the matter, … Continue reading
Regeneron v. Mylan, “It Ain’t Necessarily So.”
Regeneron v. Mylan, appeal nos. 2024-2058, 2024-2147 (Fed. Cir., March 5, 2025) is the most recent appeal in a long line of Hatch-Waxman suits filed by Regeneron to block generic versions of its VEGF antagonist (or “trap”) EYLEA®, that is … Continue reading
Posted in Inherency
Leave a comment
Obviousness-type double patenting in the Age of the Twenty-Year Term and Patent Term Adjustment
Obviousness-type double patenting (ODP) attempts to prevent the term of a “reference patent” claiming an obvious variant of a parent patent to exceed the term of the parent. This fulfills the mandate of the patent statute of “one patent per … Continue reading
Allergan v. Sun – A Glidant Slips Past the Written Description Requirement
The most interesting part of this decision by the Fed. Cir. (No. 24- 1061, Aug. 13, 2024) is that the court was faced with an argument by Sun that Allergan’s claims in U.S. Pat. No.11,311,516 et al. are invalid as … Continue reading